Pharma's Almanac TV
PA TV
Follow the Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
T-Cell
12 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Cell Therapy
Allogeneic T Cell Therapies: Efficient Commercial Manufacturing Readiness using “Manufacturing by Design” Methodology
PAO-12-20-CL-01
Strategic Collaboration
Bayer and Atara Biotherapeutics Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors
PR-M11-20-030
Natural Killer T cells
Combating Cancer and Other Diseases with Supercharged NKT Cells
PAP-Q4-20-CL-005
In Conversation
In Conversation: NantKwest — Harnessing Natural Killer Cells to Treat Cancer
PAP-Q1-20-CL-016
T-Cell
Promoting T-Cell Survival
PAO-M07-19-NI-008
Preclinical Results
Tessa Therapeutics Presents Preclinical Results Showing Enhanced T Cell Responses Against HER2-Positive Solid Tumors Using Combination CAR T Cell Therapy
PR-M05-19-NI-007
Immunotherapy
Researchers Report SX-682 Could Enhance Multiple Forms of T Cell-Based Immunotherapies in Solid Tumors
PR-M04-19-NI-040
Oncology
Tumor Derived T cells Demonstrate Potential Against Ovarian Cancer
PAO-M03-18-NI-020
CAR T
Thermo Fisher Gets Key Customer for Its Cell Therapy Activation Reagents
PAO-M01-18-NI-006
Drug Development
Memory T Cells Fit to be Cross Trained
PAO-M12-17-NI-027
Partnership
Magnetic Bead Technology Activates Novartis’ CAR-T Therapy
PAO-M09-17-NI-007
Innovation
Research Collaboration Will Focus on the Development of New CAR T-Cell Treatments
PAO-M07-17-NI-007
